Bills › 88th General Assembly
Relating to the classification of MDMA as a schedule I controlled substance
Where it is now
- Done: IntroducedFebruary 20, 2019
- Done: SubcommitteeFebruary 5, 2020
- Stopped: House committeeDied when the General Assembly ended
- Next: Passes the House
- Next: Senate committee
- Next: Passes the Senate
- Next: To the Governor
- Next: Signed into law
Died when the session ended The 2020 session adjourned on June 14, 2020, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?
What’s in it
This bill relates to the classification of MDMA (3,4-methylenedioxymethamphetamine) as a schedule I controlled substance. The bill allows the board of pharmacy to reclassify MDMA for medicinal purposes. The bill also provides that the classification as a schedule I controlled substance under Code section 124.204 and the penalties specified in Code section 124.401 do not apply to MDMA when utilized for medicinal purposes pursuant to rules of the board of pharmacy. Current law provides that the manufacture, delivery, or possession with the intent to manufacture or deliver MDMA is a class “C” felony pursuant to Code section 124.401(1)(c)(9). A class “C” felony is punishable by confinement for no more than years and a fine of at least $1,000 but not more than $10,000.
House subcommittee
Named February 5, 2020. It hasn’t reported yet.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part